C Diff Molecular

C Diff Molecular

1780 bookmarks
Custom sorting
A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile | bioRxiv
A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile | bioRxiv
Antimicrobial resistance (AMR) plays an important role in the pathogenesis and spread of Clostridioides difficile infection (CDI), the leading healthcare-related gastrointestinal infection in the world. An association between AMR and CDI outbreaks is well documented, however, data is limited to a few 'epidemic' strains in specific geographical regions. Here, through detailed analysis of 10,330 publicly-available C. difficile genomes from strains isolated worldwide (spanning 270 multilocus sequence types (STs) across all known evolutionary clades), this study provides the first species-wide snapshot of AMR genomic epidemiology in C. difficile . Of the 10,330 C. difficile genomes, 4,532 (43.9%) in 89 STs across clades 1 - 5 carried at least one genotypic AMR determinants, with 901 genomes (8.7%) carrying AMR determinants for three or more antimicrobial classes (multidrug-resistant, MDR). No AMR genotype was identified in any strains belonging to the cryptic clades. C. difficile from Australia/New Zealand had the lowest AMR prevalence compared to strains from Asia, Europe and North America (p
·biorxiv.org·
A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile | bioRxiv
Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection | mBio
Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection | mBio
Clostridioides difficile is a noteworthy pathogen in patients with inflammatory bowel disease (IBD). Patients with IBD who develop concurrent C. difficile infection (CDI) experience increased morbidity and mortality. IBD is associated with intestinal inflammation and alterations of the gut microbiota, both of which can diminish colonization resistance to C. difficile. Here, we describe the development of a mouse model to explore the role that IBD-induced changes of the gut microbiome play in susceptibility to C. difficile. Helicobacter hepaticus, a normal member of the mouse gut microbiota, triggers pathological inflammation in the distal intestine akin to human IBD in mice that lack intact interleukin 10 (IL-10) signaling. We demonstrate that mice with H. hepaticus-induced IBD were susceptible to C. difficile colonization in the absence of other perturbations, such as antibiotic treatment. Concomitant IBD and CDI were associated with significantly worse disease than observed in animals with colitis alone. Development of IBD resulted in a distinct intestinal microbiota community compared to that of non-IBD controls. Inflammation played a critical role in the susceptibility of animals with IBD to C. difficile colonization, as mice colonized with an isogenic mutant of H. hepaticus that triggers an attenuated intestinal inflammation maintained full colonization resistance. These studies with a novel mouse model of IBD and CDI emphasize the importance of host responses and alterations of the gut microbiota in susceptibility to C. difficile colonization and infection in the setting of IBD. IMPORTANCE The incidence of C. difficile infection (CDI) has increased significantly among patients with IBD, independently of antibiotic use, yet the relationship between IBD and increased risk for CDI remains to be understood. Our study sought to describe and utilize an antibiotic-independent mouse model to specifically explore the relationship between the IBD-associated gut and susceptibility to C. difficile colonization and CDI development. We demonstrate that the development of IBD is sufficient to render mice susceptible to C. difficile colonization and results in significantly worse disease than IBD alone. Furthermore, this model requires IBD-induced inflammation to overcome colonization resistance to C. difficile. This model recapitulates human IBD and CDI comorbidity and will aid in developing new clinical approaches to predict, diagnose, and treat C. difficile infection in the IBD population.
·journals.asm.org·
Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection | mBio
Genomic evolution and virulence association of Clostridioides difficile sequence type 37 (ribotype 017) in China()
Genomic evolution and virulence association of Clostridioides difficile sequence type 37 (ribotype 017) in China()
Clostridioides difficile sequence type (ST) 37 (ribotype 017) is one of the most prevalent genotypes circulating in China. However, its genomic evolution and virulence determinants were rarely explored. Whole-genome sequencing, phylogeographic and phylogenetic analyses were conducted for C …
·pubmed.ncbi.nlm.nih.gov·
Genomic evolution and virulence association of Clostridioides difficile sequence type 37 (ribotype 017) in China()
C. diff. Spores and More C. diff. Spores and More
C. diff. Spores and More C. diff. Spores and More
“C. diff. Spores and More” is an educational program providing you with up-to-date information pertaining to C. diff. and Healthcare-Associated infections.
·voiceamerica.com·
C. diff. Spores and More C. diff. Spores and More
ESCMID: ESGCD
ESCMID: ESGCD
Welcome to the European Society of Clinical Microbiology and Infectious Diseases - Study Group for Clostridioides difficile
·escmid.org·
ESCMID: ESGCD
Major genetic discontinuity and novel toxigenic species in Clostridioides difficile taxonomy
Major genetic discontinuity and novel toxigenic species in Clostridioides difficile taxonomy
Clostridioides difficile infection (CDI) remains an urgent global One Health threat. The genetic heterogeneity seen across C. difficile underscores its wide ecological versatility and has driven the significant changes in CDI epidemiology seen in the last 20 years. We analysed an inter …
·pubmed.ncbi.nlm.nih.gov·
Major genetic discontinuity and novel toxigenic species in Clostridioides difficile taxonomy
Clostridioides difficile Infection and Liver Cirrhosis - A Retrospective, Cohort Study
Clostridioides difficile Infection and Liver Cirrhosis - A Retrospective, Cohort Study
Our study noted a more severe disease presentation and higher mortality in patients with cirrhosis admitted with CDI. Further studies are required for better understanding of the clinical course of CDI in cirrhosis and to evaluate the need for early intervention in this patient group.
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile Infection and Liver Cirrhosis - A Retrospective, Cohort Study
Detection of Free Toxin B in the Stool of Asymptomatic Clostridioides difficile Carriers by the Cell Cytotoxicity Neutralization Assay
Detection of Free Toxin B in the Stool of Asymptomatic Clostridioides difficile Carriers by the Cell Cytotoxicity Neutralization Assay
Cell cytotoxicity neutralization assay (CCNA) is considered to be a gold standard to diagnose Clostridioides difficile infections. We performed CCNA on 77 consecutive admission screening rectal swabs from asymptomatic toxigenic C. difficile carriers. Thirty-nine percent of specimens fr …
·pubmed.ncbi.nlm.nih.gov·
Detection of Free Toxin B in the Stool of Asymptomatic Clostridioides difficile Carriers by the Cell Cytotoxicity Neutralization Assay
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections - PubMed
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections - PubMed
In our study, concomitant GI infections are associated with more severe symptoms in IMDC patients. Antimicrobial treatment did not circumvent the need for immunosuppressive therapy for IMDC or improve the clinical outcome. Concomitant GI infection was not associated with a higher risk of IMDC recurr …
·pubmed.ncbi.nlm.nih.gov·
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections - PubMed
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
Clostridioides difficile infection (CDI) remains a major global cause of gastrointestinal infection, with significant associated morbidity, mortality and impact upon healthcare system resources. Recent antibiotic use is a key risk factor for the condition, with the marked antibiotic-mediated …
·pubmed.ncbi.nlm.nih.gov·
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
Clostridioides difficile specific DNA adenine methyltransferase CamA squeezes and flips adenine out of DNA helix
Clostridioides difficile specific DNA adenine methyltransferase CamA squeezes and flips adenine out of DNA helix
Clostridioides difficile infections are an urgent medical problem. The newly discovered C. difficile adenine methyltransferase A (CamA) is specified by all C. difficile genomes sequenced to date (>300), but is rare among other bacteria. CamA is an orphan methyltransferase, unassociated with a res …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile specific DNA adenine methyltransferase CamA squeezes and flips adenine out of DNA helix
Understanding the Microbiome | The Power of the Microbiome
Understanding the Microbiome | The Power of the Microbiome
The human microbiome has an important influence on metabolism and immunity. Learn more about how the power of the microbiome may be used to break the cycle of recurrent C diff, here.
·microbiome.ferring.com·
Understanding the Microbiome | The Power of the Microbiome
The repertoire of ABC proteins in Clostridioides difficile
The repertoire of ABC proteins in Clostridioides difficile
ATP-binding cassette (ABC) transporters belong to one of the largest membrane protein superfamilies, which function in translocating substrates across biological membranes using energy from ATP hydrolysis. Currently, the classification of ABC transporters in Clostridioides difficile is not co …
·pubmed.ncbi.nlm.nih.gov·
The repertoire of ABC proteins in Clostridioides difficile
Prevalence and impact of antimicrobial resistance in gastrointestinal infections: A review
Prevalence and impact of antimicrobial resistance in gastrointestinal infections: A review
Antimicrobial resistance has become a worldwide problem due to its excessive increase in recent years. The aim of the present review was to bring together data from different articles describing the levels of antimicrobial resistance in the most common gastrointestinal infections reported across the …
·pubmed.ncbi.nlm.nih.gov·
Prevalence and impact of antimicrobial resistance in gastrointestinal infections: A review
Large Clostridial Toxins: Mechanisms and Roles in Disease
Large Clostridial Toxins: Mechanisms and Roles in Disease
SUMMARY Large clostridial toxins (LCTs) are a family of bacterial exotoxins that infiltrate and destroy target cells. Members of the LCT family include Clostridioides difficile toxins TcdA and TcdB, Paeniclostridium sordellii toxins TcsL and TcsH, Clostridium novyi toxin TcnA, and Clostridium perfringens toxin TpeL. Since the 19th century, LCT-secreting bacteria have been isolated from the blood, organs, and wounds of diseased individuals, and LCTs have been implicated as the primary virulence factors in a variety of infections, including C. difficile infection and some cases of wound-associated gas gangrene. Clostridia express and secrete LCTs in response to various physiological signals. LCTs invade host cells by binding specific cell surface receptors, ultimately leading to internalization into acidified vesicles. Acidic pH promotes conformational changes within LCTs, which culminates in translocation of the N-terminal glycosyltransferase and cysteine protease domain across the endosomal membrane and into the cytosol, leading first to cytopathic effects and later to cytotoxic effects. The focus of this review is on the role of LCTs in infection and disease, the mechanism of LCT intoxication, with emphasis on recent structural work and toxin subtyping analysis, and the genomic discovery and characterization of LCT homologues. We provide a comprehensive review of these topics and offer our perspective on emerging questions and future research directions for this enigmatic family of toxins.
·t.co·
Large Clostridial Toxins: Mechanisms and Roles in Disease
Clostridioides difficile spores stimulate inflammatory cytokine responses and induce cytotoxicity in macrophages
Clostridioides difficile spores stimulate inflammatory cytokine responses and induce cytotoxicity in macrophages
Clostridioides difficile is a gram-positive, spore-forming anaerobic bacterium, and the leading cause of antibiotic-associated diarrhea worldwide. During C. difficile infection, spores germinate in the presence of bile acids into vegetative cells that subsequently colonize the large intestine and pr …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile spores stimulate inflammatory cytokine responses and induce cytotoxicity in macrophages
Large Clostridial Toxins: Mechanisms and Roles in Disease
Large Clostridial Toxins: Mechanisms and Roles in Disease
Large clostridial toxins (LCTs) are a family of bacterial exotoxins that infiltrate and destroy target cells. Members of the LCT family include Clostridioides difficile toxins TcdA and TcdB, Paeniclostridium sordellii toxins TcsL and TcsH, Clostridium novyi toxin TcnA, and Clostridium perfringens to …
·pubmed.ncbi.nlm.nih.gov·
Large Clostridial Toxins: Mechanisms and Roles in Disease
IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of C. difficile Infection
IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of C. difficile Infection
Clostridioides difficile infection (CDI) is associated with a high risk for complications and death, which requires identifying severe patients and treating them accordingly. We examined the serum level of six cytokines and chemokines (IL-16, IL-21, IL-23, IL-33, BCA-1, TRAIL) and investigate …
·pubmed.ncbi.nlm.nih.gov·
IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of C. difficile Infection
Postinfection Irritable Bowel Syndrome Following Clostridioi... : Journal of Clinical Gastroenterology
Postinfection Irritable Bowel Syndrome Following Clostridioi... : Journal of Clinical Gastroenterology
hods: We systematically searched Medline, Embase, and Web of Science from inception through January 20, 2020 for cohort studies assessing PI-IBS following CDI. Primary outcome was pooled prevalence calculated using inverse variance heterogeneity model [MetaXL (v. 5.3)]. A priori subgroup analyses were done [by irritable bowel syndrome (IBS) diagnostic criteria-Rome vs. others, time of IBS diagnosis-6 mo, exclusion or inclusion of pre-existing IBS and CDI treatment-antibiotic with fecal microbiota transplantation vs. antibiotic only]. Heterogeneity was considered substantial if I2>50%. Results: From 2007 to 2019, 15 studies were included (10 prospective, 5 retrospective; 9 full-text, 6 abstracts). Data from 1218 patients were included in the quantitative analysis. Risk of bias was low in 7, medium in 4 and high in 4 studies. Pooled prevalence of PI-IBS was 21.1% (95% confidence interval, 8.2%-35.7%), I2=96%. Common PI-IBS subtypes were diarrhea-predominant in 46.3% (50) patients, and mixed in 33.3% (36) patients. Subgroup analyses by IBS diagnostic criteria, time of IBS diagnosis or CDI treatment did not significantly change the primary outcome (all P>0.05), nor decrease heterogeneity. Funnel plot analysis revealed publication bias. Conclusions: Over 20% of patients develop PI-IBS after CDI. Factors such as diagnostic criteria for IBS and CDI treatment did not affect prevalence, though small numbers limit the confidence in these conclusions. Larger, well conducted studies are needed to study PI-IBS in CDI. S.K.: is the guarantor of the article and accepts full responsibility for the conduct of the study; also had access to the data and control of decision to publish. S.S.: contributed for study design, data collection and interpretation, analysis, drafting, and revision of manuscript. K.S.: contributed for data interpretation, analysis, drafting, and revision of manuscript. S.S.: contributed for data collection, drafting, and revision of manuscript. M.G.: contributed for data interpretation, drafting, and revision of manuscript. D.P.: contributed for concept, drafting, and revision of manuscript. S.K.: contributed for concept, data interpretation, drafting, and revision of manuscript. Institutional funds were used for the study. M.G. is supported by NIDDK K23 103911 and R03 120475. The authors declare that they have nothing to disclose. Address correspondence to: Sahil Khanna, MBBS, MS, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 (e-mail: khanna.sahil@mayo.edu). Received October 9, 2020 Accepted February 19, 2021 Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved....
·journals.lww.com·
Postinfection Irritable Bowel Syndrome Following Clostridioi... : Journal of Clinical Gastroenterology